RC
AMGN icon

Riversville Capital’s Amgen AMGN Stock Holding History

Riversville Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-22,314
Closed -$2.55M – 29
2013
Q4 		$2.55M Buy
22,314
+8,709
+64% +$991K 1.43% 22
2013
Q3 		$1.52M Hold
13,605
– – 0.84% 42
2013
Q2 		$1.34M Buy
+13,605
New +$1.41M 0.78% 44

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Riversville Capital's AMGN Position: Q1 2014 in Review

Riversville Capital sold out of Amgen (AMGN) in Q1 2014, closing a stake of 22,314 shares — an estimated $2.55M sold.

Riversville Capital first reported a position in AMGN in Q2 2013 and held it in 3 quarters. The position peaked at $2.55M in Q4 2013. 1,180 funds tracked by Wall St. Rank hold AMGN as of Q1 2014.

  • Riversville Capital reported no remaining Amgen position as of Q1 2014 after selling out during the quarter.
  • Riversville Capital sold 22,314 Amgen shares in Q1 2014, an estimated $2.55M.
  • Riversville Capital first reported a position in Amgen in Q2 2013 and held it in 3 quarters.
  • Riversville Capital's Amgen position peaked at $2.55M in Q4 2013.
  • 1,180 funds tracked by Wall St. Rank held Amgen as of Q1 2014.

Based on Riversville Capital's 13F filing for Q1 2014, filed 10 Apr 2014.